GSK3008348   Click here for help

GtoPdb Ligand ID: 12736

Synonyms: GSK-3008348
Compound class: Synthetic organic
Comment: GSK3008348 is an inhalational inhibitor of integrin αvβ6 that was developed for potential to treat idiopathic pulmonary fibrosis (IPF) [2]. Structurally it is an arginyl-glycinyl-aspartic acid (RGD)-mimetic that replicates the amino acid binding motif of αvβ6 endogenous ligand latency associated peptide-1 (LAP1) [1] that is derived from the N-terminal region of the TGFβ gene product [4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 80.53
Molecular weight 487.64
XLogP 1.97
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NN(C(=C1)C)C2=CC(=CC=C2)[C@H](CC(=O)O)CN3CC[C@@H](CCC4=CC=C5CCCNC5=N4)C3
Isomeric SMILES CC=1C=C(C)N(N1)C2=CC=CC([C@H](CC(O)=O)CN3C[C@@H](CC3)CCC=4C=CC5=C(N4)NCCC5)=C2
InChI InChI=1S/C29H37N5O2/c1-20-15-21(2)34(32-20)27-7-3-5-24(16-27)25(17-28(35)36)19-33-14-12-22(18-33)8-10-26-11-9-23-6-4-13-30-29(23)31-26/h3,5,7,9,11,15-16,22,25H,4,6,8,10,12-14,17-19H2,1-2H3,(H,30,31)(H,35,36)/t22-,25-/m1/s1
InChI Key ZMXBIIQMSGOIRZ-RCZVLFRGSA-N